HomeBUSINESS
BUSINESS

Fujifilm, Takeda Strike Deal on iPS Cell-Based Heart Therapy
(Feb.9.2018)

Fujifilm and Takeda Pharmaceutical have inked a collaboration to develop regenerative medicine therapies based on iPS cell-derived cardiac cells for the treatment of heart failure, the two companies said on February 8 ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 20.

News Calendar